The Political Economy Reader最新文献_第2页

N. Gregory Mankiw, “Defending the One Percent” (2013)* n·格雷戈里·曼昆，《捍卫1%》(2013)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-41

Naazneen H Barma, Steve Vogel

引用次数: 0

Friedrich A. Hayek, The Road to Serfdom (1944)* 弗里德里希·哈耶克:《通往奴役之路》(1944)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-8

Naazneen H Barma, S. Vogel

引用次数: 0

Milton Friedman, Capitalism and Freedom (1962)* 米尔顿·弗里德曼:《资本主义与自由》(1962)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-9

Naazneen H Barma, Steve Vogel

引用次数: 0

Yuen Yuen Ang, How China Escaped the Poverty Trap (2016)* 《中国如何摆脱贫困陷阱》(2016)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-28

Naazneen H Barma, Steve Vogel

引用次数: 0

The COVID-19 Pandemic COVID-19大流行

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-47

Naazneen H Barma, S. Vogel

引用次数: 0

Historical Perspectives 历史的视角

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-16

Naazneen H Barma, S. Vogel

{"title":"Historical Perspectives","authors":"Naazneen H Barma, S. Vogel","doi":"10.4324/9781003047162-16","DOIUrl":"https://doi.org/10.4324/9781003047162-16","url":null,"abstract":"NOTHING could please me more than to be with you at this meeting and to have the privilege of introducing this symposium. The time does not seem so very long ago since I went frequently to meetings such as this. In those days, and I speak of the 1950s, the pain of inflammation was treated with aspirin, phenacetin, and phenylbutazone. These were, and are, useful analgesics but they clearly have their limitations. Indomethacin was just starting its long path from the laboratory to the clinic, and it was by no means clear that the early versions of this molecule would have clinical utility, especially since the animal models in those days were of such speculative value. At this stage fate intervened in the form of a letter from Dr Walter Bauer, Professor of Rheumatology at Harvard Medical School and the 'grey eminence' of American rheumatologists. On 12 Feburary, 1953, he wrote to Dr Randolph Major, our then Director of Research. His request asked if Merck could synthesize a better aspirin. He thereby eliminated new corticosteroids from consideration but still left a good deal of room for speculation. As a consequence I paid a visit to Cambridge and tried to clarify whether Dr Bauer had a pharmacological or a chemical equivalent of aspirin, or perhaps both, in mind. After much discussion and cogitation, we concluded that our goal should be a salicylic acid molecule whose pharmacological properties were superior in terms of safety and efficacy to aspirin itself. Pursuit of this objective required a strong dose of optimism, since such an abundance of salicylates had been synthesized and tested without any great progress. After all, extracts of willow bark had been used for a great variety of agues and so-called 'intermitting disorders' from the earliest of times. Even the effectiveness of salicylates as a specific remedy for rheumatic fever was reported in the Lancet (Maclagan, 1876). With the advent of synthetic chemistry, salicylic acid became a medicinal prototype for which improvements were sought early and often. In fact, there are few prototypes which have so steadfastly refused to allow themselves to be improved on as aspirin. Nonetheless, through persistence and good fortune, a group of collaborators succeeded in synthesizing a new molecule which was brought through development and into the clinic. May I express the hope that, as you weigh the data, you will feel that it approaches what Dr Bauer had in mind.","PeriodicalId":267163,"journal":{"name":"The Political Economy Reader","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127756567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Karl Polanyi, The Great Transformation (1944)* 卡尔·波兰尼，《大转型》(1944)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-11

Naazneen H Barma, S. Vogel

引用次数: 0

Jeremy Caradonna et al., “A Call to Look Past An Ecomodernist Manifesto: A Degrowth Critique” (2015)* Jeremy Caradonna等人，“呼吁回顾过去的生态现代主义宣言:去增长批判”(2015)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-36

Naazneen H Barma, Steve Vogel

引用次数: 0

Inequality 不平等

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-40

Naazneen H Barma, Steve Vogel

引用次数: 0

Karl Marx and Friedrich Engels, “The Communist Manifesto” (1848)* 卡尔·马克思和弗里德里希·恩格斯，《共产党宣言》(1848年)*

The Political Economy Reader Pub Date : 2021-07-05 DOI: 10.4324/9781003047162-5

Naazneen H Barma, Steve Vogel

引用次数: 0